Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Other financing activities (2016 - 2025)

Merit Medical Systems' Other financing activities history spans 12 years, with the latest figure at $11.7 million for Q4 2025.

  • For Q4 2025, Other financing activities rose 37.24% year-over-year to $11.7 million; the TTM value through Dec 2025 reached $42.0 million, up 63.11%, while the annual FY2025 figure was $42.0 million, 63.11% up from the prior year.
  • Other financing activities for Q4 2025 was $11.7 million at Merit Medical Systems, down from $12.5 million in the prior quarter.
  • Across five years, Other financing activities topped out at $13.8 million in Q4 2023 and bottomed at $4.9 million in Q1 2024.
  • The 3-year median for Other financing activities is $8.5 million (2024), against an average of $9.1 million.
  • The largest annual shift saw Other financing activities plummeted 38.22% in 2024 before it soared 109.5% in 2025.
  • A 3-year view of Other financing activities shows it stood at $13.8 million in 2023, then tumbled by 38.22% to $8.5 million in 2024, then soared by 37.24% to $11.7 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Other financing activities are $11.7 million (Q4 2025), $12.5 million (Q3 2025), and $9.9 million (Q2 2025).